Patents by Inventor Gregory Marszalek

Gregory Marszalek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intermediates for imidazonaphthyridines
    Publication number: 20080091010
    Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.
    Type: Application
    Filed: December 6, 2007
    Publication date: April 17, 2008
    Applicant: Graceway Pharmaceuticals, LLC
    Inventors: John Gerster, Kyle Lindstrom, Stephen Crooks, Philip Heppner, Gregory Marszalek, Peter Maye, Bryon Merrill, John Mickelson, Michael Rice
  • Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
    Publication number: 20070099901
    Abstract: Imidazo-quinoline, -pyridine, and -naphthyridine ring systems substituted at the 1-position, pharmaceutical compositions containing the compounds, intermediates, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
    Type: Application
    Filed: November 24, 2004
    Publication date: May 3, 2007
    Applicant: 3M INNOVATIVE PROPERTIES COMPANY
    Inventors: Larry Krepski, Joseph Dellaria, Daniel Duffy, David Amos, Bernhard Zimmermann, David Squire, Gregory Marszalek, Philip Heppner, Tushar Kshirsagar
  • INTERMEDIATES FOR IMIDAZONAPHTHYRIDINES
    Publication number: 20060128674
    Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are disclosed.
    Type: Application
    Filed: February 13, 2006
    Publication date: June 15, 2006
    Inventors: John Gerster, Kyle Lindstrom, Stephen Crooks, Philip Heppner, Gregory Marszalek, Peter Maye, Bryon Merrill, John Mickelson, Michael Rice
  • IMIDAZONAPHTHYRIDINES
    Publication number: 20050288320
    Abstract: Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the compounds and intermediates useful in the preparation of the compounds are also disclosed.
    Type: Application
    Filed: July 25, 2005
    Publication date: December 29, 2005
    Inventors: John Gerster, Kyle Lindstrom, Stephen Crooks, Philip Heppner, Gregory Marszalek, Peter Maye, Bryon Merrill, John Mickelson, Michael Rice
  • Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
    Publication number: 20050026943
    Abstract: Thiazolo-, oxazolo- and selenazolo[4,5-c]quinolin-4-amines and analogs thereof are described including methods of manufacture and the use of novel intermediates. The compounds are immunomodulators and induce cytokine biosynthesis, including interferon and/or tumor biosynthesis, necrosis factor, and inhibit the T-helper-type 2 immune response. The compounds are further useful in the treatment of viral and neoplastic diseases.
    Type: Application
    Filed: August 25, 2004
    Publication date: February 3, 2005
    Inventors: John Gerster, Kyle Lindstrom, Gregory Marszalek, Michael Rice